We are live on
!
Find out more
GC
Guggenheim Capital Portfolio holdings
AUM
$12.9B
1-Year Est. Return
27.3%
This Fund
S&P 500
This Quarter
Est. Return
-12.36%
1 Year Est. Return
+27.3%
3 Year Est. Return
+83.37%
5 Year Est. Return
+104.66%
10 Year Est. Return
+386.48%
AUM
$12.7B
AUM Growth
-$3.96B
(-24%)
Cap. Flow
-$1.66B
Cap. Flow
% of AUM
-13.11%
Top 10 Holdings %
Top 10 Hldgs %
14.02%
Holding
2,200
New
84
Increased
771
Reduced
1,166
Closed
158
Top Buys
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$68.5M |
| 2 |
PSTH
Pershing Square Tontine Holdings, Ltd.
PSTH
|
+$68.1M |
| 3 |
JPMorgan Chase
JPM
|
+$57.2M |
| 4 |
Microsoft
MSFT
|
+$56.6M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$52.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.53% |
| 2 | Financials | 16.02% |
| 3 | Healthcare | 10.59% |
| 4 | Real Estate | 7.38% |
| 5 | Consumer Discretionary | 6.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1551
Delek US
DK
$3.58B
| $538K | ﹤0.01% |
20,839
-4,827
| -19% | -$130K |
|
1552
FTI Consulting
FCN
$4.18B
| $538K | ﹤0.01% |
2,977
-342
| -10% | -$56.4K |
|
|
DMC
1553
Del Monte Corp
DMC
$1.45B
| $537K | ﹤0.01% |
18,194
+1,407
| +8% | +$35.9K |
|
1554
Safety Insurance
SAFT
$1.52B
| $534K | ﹤0.01% |
5,502
-14,628
| -73% | -$1.32M |
|
|
ASG
1555
Liberty All-Star Growth Fund
ASG
$341M
| $532K | ﹤0.01% |
91,250
-682
| -0.7% | -$4.25K |
|
1556
SkinHealth Systems
SKIN
$85.7M
| $532K | ﹤0.01% |
41,342
+8,257
| +25% | +$111K |
|
1557
Amphastar Pharmaceuticals
AMPH
$916M
| $531K | ﹤0.01% |
15,244
-15,911
| -51% | -$568K |
|
1558
Primerica
PRI
$10B
| $529K | ﹤0.01% |
4,419
+2,742
| +164% | +$345K |
|
|
AWF
1559
AllianceBernstein Global High Income Fund
AWF
$872M
| $527K | ﹤0.01% |
53,969
-2,110
| -4% | -$21.4K |
|
1560
Cohen & Steers Infrastructure Fund
UTF
$3.04B
| $525K | ﹤0.01% |
20,748
+5,014
| +32% | +$135K |
|
1561
Booz Allen Hamilton
BAH
$9.15B
| $524K | ﹤0.01% |
5,795
-7,021
| -55% | -$599K |
|
1562
Corcept Therapeutics
CORT
$12B
| $524K | ﹤0.01% |
22,028
-1,948
| -8% | -$42.4K |
|
1563
Hain Celestial
HAIN
$53.7M
| $524K | ﹤0.01% |
22,093
+3,937
| +22% | +$112K |
|
1564
Northern Oil and Gas
NOG
$2.35B
| $524K | ﹤0.01% |
20,755
-1,186
| -5% | -$34.5K |
|
1565
Blackstone Mortgage Trust
BXMT
$2.38B
| $523K | ﹤0.01% |
18,907
-18,463
| -49% | -$559K |
|
1566
Donaldson
DCI
$11.4B
| $519K | ﹤0.01% |
10,778
-9,199
| -46% | -$463K |
|
1567
Viavi Solutions
VIAV
$9.66B
| $515K | ﹤0.01% |
38,947
-23,971
| -38% | -$345K |
|
1568
StoneX
SNEX
$7.94B
| $514K | ﹤0.01% |
33,332
+2,324
| +7% | +$33.6K |
|
|
BRG
1569
DELISTED
Bluerock Residential Growth REIT, Inc.
BRG
| $512K | ﹤0.01% |
+19,465
| New | +$514K |
|
|
NARI
1570
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $510K | ﹤0.01% |
+7,501
| New | +$539K |
|
1571
Kemper
KMPR
$1.68B
| $508K | ﹤0.01% |
10,605
-2,598
| -20% | -$130K |
|
1572
Freshpet
FRPT
$3.22B
| $505K | ﹤0.01% |
9,723
+2,868
| +42% | +$221K |
|
|
SFBS
1573
ServisFirst Bancshares
SFBS
$4.86B
| $505K | ﹤0.01% |
6,393
-8,157
| -56% | -$664K |
|
1574
Gray Television
GTN
$552M
| $504K | ﹤0.01% |
29,816
-1,111
| -4% | -$21.6K |
|
1575
Thomson Reuters
TRI
$44.1B
| $504K | ﹤0.01% |
4,588
-11,416
| -71% | -$1.21M |
|
Similar funds
TRSOTSOK
AIM
CII
AAMU
WANY
ACA
ZIG
Guggenheim Capital's Q2 2022 Portfolio in Review
As of Q2 2022, Guggenheim Capital held 2,200 positions worth $12.7B, down 24% from $16.6B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Guggenheim Capital withdrew a net $1.66B in Q2 2022, closing 158 positions and reducing 1,166 holdings. Its most notable exit was BLACKROCK MUNIYIELD CALIFORNIA QUALITY FUND, INC, an estimated $13.1M position sold in full.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Guggenheim Capital opened a new position in ESAB worth $3.14M.
- Guggenheim Capital's largest Q2 2022 buy was ESAB: 71,750 shares worth $3.14M.
- Guggenheim Capital added most to Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share in Q2 2022, an estimated $25.1M increase.
- Guggenheim Capital's biggest Q2 2022 reduction was Apple, cutting an estimated $68.5M.
- Guggenheim Capital fully exited BLACKROCK MUNIYIELD CALIFORNIA QUALITY FUND, INC in Q2 2022, selling an estimated $13.1M.
- Guggenheim Capital's ten largest holdings make up 14% of its $12.7B portfolio in Q2 2022.
- Guggenheim Capital opened 84 new positions and closed 158 in Q2 2022.
- Guggenheim Capital's portfolio value fell 24% quarter-over-quarter to $12.7B.
Based on Guggenheim Capital's 13F filing for Q2 2022, filed 15 Aug 2022.